Interested in licensing this patent?
MTEC can help explore whether this patent might be available for licensing for your application.
Publication Number
US-12318275-B2
Publication Date
2025-06-03
Expiration Date
Abstract
A hybrid medical device that can aid in reconstructive or augmentative surgery of the breast is disclosed. The device can utilize a suitable biological collagen tissue matrix combined with a synthetic material, for example, that can impart a high initial strength to the repair site while permitting proper healing and revitalization of the implanted device.
Core Innovation
The invention relates to an implantable support device that includes a scaffold having a first end, a second end, a first edge, and a second edge. The scaffold comprises a biological material and is configured with holes, apertures, slits, and/or pores so that tissue and/or fluid is passable through the holes, apertures, slits, and/or pores, and the scaffold supports tissue ingrowth and/or fluid passage.
The implantable support device further includes a first leader and a second leader. The first leader has a first section and a second section between the first end and the second end, and includes a first apex and a second apex with the first apex and second apex farther apart than the first section and second section, including oppositional relationships as recited in the claims.
The second leader extends from the first edge to the second edge and extends over the first section and the second section or over the first leader as recited. In at least some claim formulations, the first leader is configured to deliver a resistive force through the implantable support device, and in some embodiments the first leader and the second leader comprise poly-L-glycolic acid (PLGA).
Claims Coverage
The document provides three independent claims. Across these independent claims, the core inventive coverage is the combination of a biological-material scaffold with passable holes, apertures, slits, and/or pores and a two-leader arrangement in which the first leader is defined by section/apex geometry and, in some claim sets, is configured to deliver a resistive force; the second leader spans between scaffold edges and extends over the first leader or the first and second sections; in some formulations both leaders comprise PLGA.
Two-leader implantable support with apical spacing geometry over a biological scaffold
An implantable support device comprising a scaffold of biological material with a first leader having first and second sections and first and second apices, where the first apex and second apex are farther apart than the first section and the second section; and a second leader extending from the first edge to the second edge and extending over the first section and the second section.
Resistive-force leader and passable scaffold microfeatures
An implantable support device comprising a scaffold with first and second edges and a first leader having a first section and a second section between the first end and second end, wherein the first leader is configured to deliver a resistive force through the implantable support device; and a second leader extending from the first edge to the second edge and extending over the first leader; wherein the implantable support device comprises holes, apertures, slits, and/or pores and tissue and/or fluid is passable through the holes, apertures, slits, and/or pores.
Opposed apices inside a biological scaffold with passable openings and PLGA leaders
An implantable support device comprising a scaffold of biological material having first and second edges, and a first leader having a first and a second section inside the scaffold between the first end and second end, wherein the first leader has a first apex and a second apex opposite the second apex; wherein the scaffold comprises holes, apertures, slits, and/or pores and tissue and/or fluid is passable through the holes, apertures, slits, and/or pores; and wherein the first leader and second leader comprise poly-L-glycolic acid (PLGA).
Across the independent claims, the inventive combination centers on a biological-material scaffold with openings enabling tissue and/or fluid passage, together with a two-leader arrangement in which the first leader’s section/apex relationships and placement are defined, and the first leader is configured to deliver a resistive force in at least one independent-claim formulation. The second leader spans between scaffold edges and extends over the first leader or the first and second sections, and some formulations further require PLGA for both leaders.
Stated Advantages
Provides tissue and/or fluid passable through holes, apertures, slits, and/or pores of the scaffold.
The first leader is configured to deliver a resistive force through the implantable support device.
Documented Applications
No documented applications found
Interested in licensing this patent?